Comparison of the epidemiology, risk factors, outcome and degree of organ failures of patients with candidemia acquired before or during ICU treatment
Open Access
- 18 April 2012
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 16 (2) , R62
Abstract
The aim of this study was to compare the epidemiology, risk factors, severity and outcome of two types of intensive care unit (ICU) treated candidemias; namely, ICU-acquired candidemia (acquired after 48-hour ICU stay) ( ICUAC group), and those needing ICU treatment for candidemia acquired before ICU admission or during the first 48-hour ICU stay (non-ICUAC group).Keywords
This publication has 31 references indexed in Scilit:
- Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009Antimicrobial Agents and Chemotherapy, 2011
- Acquired bloodstream infection in the intensive care unit: incidence and attributable mortalityCritical Care, 2011
- Incidence, Etiology and Risk Factors Associated with Mortality of Nosocomial Candidemia in a Tertiary Care Hospital in Istanbul, TurkeyMedical Principles and Practice, 2010
- Breakthrough Invasive Candidiasis in Patients on MicafunginJournal of Clinical Microbiology, 2010
- Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unitCritical Care, 2010
- A 10-Year Survey of Antifungal Susceptibility of Candidemia Isolates from Intensive Care Unit Patients in GreeceAntimicrobial Agents and Chemotherapy, 2009
- Breakthrough Aspergillus fumigatus and Candida albicans Double Infection during Caspofungin Treatment: Laboratory Characteristics and Implication for Susceptibility TestingAntimicrobial Agents and Chemotherapy, 2009
- Treatment-related risk factors for hospital mortality in Candida bloodstream infections*Critical Care Medicine, 2008
- Epidemiology of candidemia in intensive care unitsInternational Journal of Antimicrobial Agents, 2008
- APACHE IICritical Care Medicine, 1985